The Sherman Prize Selection Committee consists of six of the nation’s preeminent IBD researchers, clinicians and advocates representing diverse areas of expertise. The Committee’s extensive review of the candidates focuses on which body of work had the most significant, enduring and inspiring impact in the fight to overcome Crohn’s disease and ulcerative colitis.
Based on the response in our inaugural year, we expect to receive a large number of qualified candidates from various walks of life — all talented and worthy of consideration. While choosing the recipients can be challenging, the Sherman Prize selection process helps ensure that the best, most qualified nominees in a given year are selected for recognition.
After formal review, the Committee’s recommendations are presented to the Sherman Prize Board of Directors, who make the final decision. The deliberation process is confidential. Only details of final Prize recipients will be made public.
Dr. David T. Rubin is Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.
Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Physicians (ACP) and an active national member of the Crohn’s & Colitis Foundation of America (CCFA), and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCFA’s Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is currently the Chair of Government and Industry Affairs for the national CCFA, and in this role has authored or co-authored position and policy statements for the Foundation on behalf of patients and professionals. He is an Associate Editor of the journal Gastroenterology and Co-Editor of the ACG On-Line Educational Universe.
Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 2nd edition, and an author or coauthor of many peer-reviewed articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the in progress ACG Guidelines for ulcerative colitis. His current research is in the area of progressive complications from uncontrolled inflammation, the doctor-patient relationship in IBD, and a variety of collaborative studies related to the microbiome and intestinal disease. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular twitter feed @IBDMD. His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.
Elisabeth R. Evans is a Family Nurse Practitioner, specializing in Inflammatory Bowel Disease at the UC San Diego Health System in La Jolla, California. She works as a team with Dr. William Sandborn to deliver best patient outcomes combining excellent medical care with psychosocial care. She earned her Masters of Science in Nursing at the University of San Diego in California.
Ms. Evans is a member of the American Association of Nurse Practitioners, the American Nurses Association, and the California Association for Nurse Practitioners. She has had her work published in such peer-reviewed journals as the American Journal of Gastroenterology, Journal of Crohn’s and Colitis, and Clinical Gastroenterology and Hepatology. She is a frequent presenter at meetings such as the Advances in Inflammatory Bowel Disease Conference.
Dr. Sunanda V. Kane is a Professor of Medicine at the Mayo Clinic. Dr. Kane has contributed over 120 papers of original research, 50 reviews, and 25 book chapters to the medical literature. She has co-edited a pocket guide to the management of IBD for practitioners, and written a book for patients on self-management. She is also the Past Chair of the National Patient Education Committee for the Crohn’s and Colitis Foundation of America. She served as the first female Associate Editor for Alimentary Pharmacology and Therapeutics and continues to serve editorial roles for Inflammatory Bowel Disease, Gastroenterology & Hepatology, and the Journal of Crohn’s and Colitis. Dr. Kane is currently the Treasurer of the American College of Gastroenterology and sits on the GI Specialty Council of the American Board of Internal Medicine. Within the Division of Gastroenterology and Hepatology, she is the Chair of Quality, where she is responsible for oversight of all quality improvement projects as well as monitoring quality metrics for the faculty. She continues to have a busy clinical practice seeing patients with inflammatory bowel disease, and she conducts research in the areas of new therapies, gender-specific issues, and medication adherence. Dr. Kane also travels to give lectures at national symposia and other medical facilities in the United States and across the world.
Dr. Dermot P. B. McGovern is the Joshua L and Lisa Z Greer Endowed Chair in Inflammatory Bowel Disease Genetics; Director of Translational Medicine for the Inflammatory Bowel and Immunobiology Research Institute; Director of Precision Medicine Initiative, Cedars-Sinai; and Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
Dr. McGovern completed his GI fellowship and obtained a PhD in complex disease genetics at the University of Oxford before moving to Cedars-Sinai, Los Angeles almost nine years ago. His group studies the genetics of the inflammatory bowel diseases in diverse populations. They are particularly interested in identifying genetic associations with clinically relevant sub-phenotypes, including associations with natural history, drug response, and the development of extra-intestinal manifestations of IBD.
Dr. McGovern’s group analyzes multi-omic datasets to identify potential therapeutic targets of IBD that “feed” the Drug Development Unit he co-directs. Dr. McGovern serves on the National Scientific Advisory Committee for the Crohn’s and Colitis Foundation of America as well as the steering committees of the National and International IBD Genetics Consortia. He also chairs the CCFA local advisory medical committee and has survived half marathons and triathlons raising money for research and awareness about IBD. He was recently elected as a member of the American Society for Clinical Investigation and also to the International Organization for the Study of IBD. Dr. McGovern was recently appointed Director of the Cedars-Sinai Precision Medicine Initiative.
Dr. Mark B. Pochapin is the Sholtz/Leeds Professor of Gastroenterology, Director of the Division of Gastroenterology, and Vice Chair of Clinical Affairs in the Department of Medicine at NYU School of Medicine / NYU Langone Health.
As a clinician and clinical researcher, Dr. Pochapin focuses on the prevention, early detection, and treatment of gastrointestinal cancers. He is dedicated to public outreach and education in this area, including the national effort to increase colorectal cancer screening and prevention. Known for his commitment to the advancement of clinical excellence and education, Dr. Pochapin has received over 30 teaching awards, including the Elliot Hochstein Teaching Award and Humanism in Medicine Award.
Dr. Pochapin is the current Treasurer of the American College of Gastroenterology, a fellow of the American Society for Gastrointestinal Endoscopy and American College of Physicians, and is a member of the American Gastroenterological Association and New York Society for Gastrointestinal Endoscopy. He is the author of What Your Doctor May Not Tell You About Colorectal Cancer.
Dr. Pochapin graduated from the University of Pennsylvania with a Bachelor of Science and Engineering degree, and received his medical degree from Cornell University Medical College. He completed his residency and chief residency in internal medicine at NewYork-Presbyterian /Weill Cornell Medical Center and a fellowship in gastroenterology at the Albert Einstein College of Medicine.
Dr. Corey A. Siegel is the Director of the Inflammatory Bowel Disease (IBD) Center at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and an Associate Professor of Medicine and of The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
Dr. Siegel received his medical degree from Tufts University School of Medicine in Boston, Massachusetts in 1998. He completed his residency in internal medicine at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Siegel served as chief medical resident at Dartmouth from 2001-2002, where he also completed a fellowship in gastroenterology. From 2004-2005, he completed a fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital in Boston, Massachusetts.
Dr. Siegel’s research interests include understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, and improving the quality of care delivered to patients with IBD. He has been funded by the NIH, AHRQ and the Crohn’s and Colitis Foundation of America (CCFA) for this work. He has lectured nationally and internationally, and published numerous journal articles and book chapters on this and other topics in IBD. Dr. Siegel is the founder of the BRIDGe group, an international research collaborative of IBD investigators. He has served as the co-chair of the CCFA Professional Education Committee, and is currently the co-chair of the CCFA’s Quality of Care Program (IBD Qorus). Dr. Siegel was inducted into the International Organization for the Study of IBD (IOIBD) in 2013. He is on the Editorial Board for Clinical Gastroenterology and Hepatology and Alimentary Pharmacology & Therapeutics, and serves as a reviewer for The American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology, Journal of Crohn’s and Colitis, Inflammatory Bowel Diseases, The Cochrane Collaboration, and Gastroenterology. He lives in Hanover, New Hampshire with his wife and three boys.